The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 26,925 | 1,400,900 | SH | SOLE | 1,400,900 | 0 | 0 | ||
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 1,932 | 100,500 | SH | Call | SOLE | 100,500 | 0 | 0 | |
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 1,932 | 100,500 | SH | Put | SOLE | 100,500 | 0 | 0 | |
| Alector, Inc. | COM | 014442107 | 13,502 | 936,371 | SH | SOLE | 936,371 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 23,639 | 245,424 | SH | SOLE | 245,424 | 0 | 0 | ||
| Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 17,764 | 425,794 | SH | SOLE | 425,794 | 0 | 0 | ||
| CymaBay Therapeutics, Inc. | COM | 23257D103 | 10,549 | 2,060,268 | SH | SOLE | 2,060,268 | 0 | 0 | ||
| Cytokinetics Incorporated | COM NEW | 23282W605 | 21,610 | 1,898,970 | SH | SOLE | 1,898,970 | 0 | 0 | ||
| Fulcrum Therapeutics, Inc. | COM | 359616109 | 11,205 | 1,687,500 | SH | SOLE | 1,687,500 | 0 | 0 | ||
| Immunomedics, Inc. | COM | 452907108 | 4,875 | 367,636 | SH | SOLE | 367,636 | 0 | 0 | ||
| Insmed Incorporated | COM | 457669307 | 25,217 | 1,429,518 | SH | SOLE | 1,429,518 | 0 | 0 | ||
| The Medicines Company | COM | 584688105 | 23,911 | 478,217 | SH | SOLE | 478,217 | 0 | 0 | ||
| Myokardia, Inc. | COM | 62857M105 | 12,421 | 238,186 | SH | SOLE | 238,186 | 0 | 0 | ||
| OptiNose, Inc. | COM | 68404V100 | 15,666 | 2,238,006 | SH | SOLE | 2,238,006 | 0 | 0 | ||
| Orchard Therapeutics PLC | ADS | 68570P101 | 6,625 | 557,700 | SH | SOLE | 557,700 | 0 | 0 | ||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 5,062 | 234,482 | SH | SOLE | 234,482 | 0 | 0 | ||
| SI-BONE, Inc. | COM | 825704109 | 3,633 | 205,621 | SH | SOLE | 205,621 | 0 | 0 | ||
| Turning Point Therapeutics, Inc. | COM | 90041T108 | 68,672 | 1,826,374 | SH | SOLE | 1,826,374 | 0 | 0 | ||
| Voyager Therapeutics, Inc. | COM | 92915B106 | 14,294 | 830,565 | SH | SOLE | 830,565 | 0 | 0 | ||